Expedition Therapeutics
Expedition Therapeutics is a biotechnology company that develops novel therapies for inflammatory and respiratory diseases. The company advances EXPD-101, an oral once-daily inhibitor of DPP1, which targets neutrophilic inflammation and is positioned for chronic obstructive pulmonary disease (COPD) and other neutrophil-driven indications. It pursues global clinical development of EXPD-101 while exploring expansion into bronchiectasis, neutrophilic asthma, and related conditions. The leadership team combines expertise in drug discovery, translational science, clinical development, and business strategy. Expedition Therapeutics operates a model that integrates in-licensing of external innovation with internally generated programs.
Domain
expeditiontx.com
Country
United StatesIndustry
BiotechnologyEmployees
1-10
Last Funding
$165.0M
Founded
2023
Tech Stack (21 technologies)
Frequently Asked Questions
What technologies does Expedition Therapeutics use?+
Expedition Therapeutics uses 21 technologies including Elementor, Font Awesome, reCAPTCHA.
What industry is Expedition Therapeutics in?+
Expedition Therapeutics operates in the Biotechnology industry.
Where is Expedition Therapeutics based?+
Expedition Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026